California State Teachers Retirement System (CalSTRS)
CRVS icon

California State Teachers Retirement System (CalSTRS)’s Corvus Pharmaceuticals CRVS Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.2K Sell
3,498
-26
-0.7% -$415 ﹤0.01% 2258
2025
Q4 		$27.1K Buy
3,524
+254
+8% +$2K ﹤0.01% 2414
2025
Q3 		$24.1K Buy
3,270
+2
+0.1% +$10 ﹤0.01% 2485
2025
Q2 		$13.1K Buy
+3,268
New +$11.9K ﹤0.01% 2638
2019
Q2 		– Sell
-21,223
Closed -$85K – 3040
2019
Q1 		$85K Hold
21,223
– – ﹤0.01% 2926
2018
Q4 		$78K Hold
21,223
– – ﹤0.01% 2950
2018
Q3 		$182K Hold
21,223
– – ﹤0.01% 2912
2018
Q2 		$233K Buy
21,223
+7,856
+59% +$87.7K ﹤0.01% 2845
2018
Q1 		$154K Hold
13,367
– – ﹤0.01% 2859
2017
Q4 		$138K Sell
13,367
-500
-4% -$6.4K ﹤0.01% 2901
2017
Q3 		$221K Sell
13,867
-1,100
-7% -$15.2K ﹤0.01% 2849
2017
Q2 		$181K Buy
14,967
+8,200
+121% +$87.5K ﹤0.01% 2939
2017
Q1 		$141K Hold
6,767
– – ﹤0.01% 2884
2016
Q4 		$97K Sell
6,767
-200
-3% -$3.04K ﹤0.01% 2948
2016
Q3 		$115K Hold
6,967
– – ﹤0.01% 2939
2016
Q2 		$99K Buy
+6,967
New +$94.1K ﹤0.01% 2975

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s CRVS Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Corvus Pharmaceuticals (CRVS) stake by 0.74% in Q1 2026, selling an estimated $415 and leaving 3,498 shares worth $51.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

California State Teachers Retirement System (CalSTRS) first reported a position in CRVS in Q2 2016 and has held it in 16 quarters since. The position peaked at $233K in Q2 2018. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 3,498 shares of Corvus Pharmaceuticals worth $51.2K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 26 Corvus Pharmaceuticals shares in Q1 2026, an estimated $415.
  • Corvus Pharmaceuticals made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2258 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Corvus Pharmaceuticals in Q2 2016 and has held it in 16 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Corvus Pharmaceuticals position peaked at $233K in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.